Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Unlock unbeatable offers today. Shop here: https://amzn.to/4cEkqYs 🎁
Martin Shkreli, the CEO of Turing Pharmaceuticals, told ABC News they will lower the price days after making headlines and getting complaints from medical groups and others online. “We’ve agreed to lower the price on Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” he told ABC News. “We think these changes will be welcomed.”
The drug called Daraprim is used to treat parasitic infections that most often occur in those with compromised immune systems due to cancer treatments or HIV infection, and it was sold for $18 per tablet before production rights were acquired by Turing Pharmaceuticals. The company is currently selling the medication for $750 per tablet -- an increase of more than 4,000 percent. Shkreli and Turing Pharmaceuticals made headlines this week due to the price increase leading to medical groups and others online complaining the company was making money on patients who need the medication.
In a statement released before Shkreli's announcement, the company said that it is aiming to create new medications to treat the disease in an effort to reduce side effects and that the higher price will help subsidize costs for developing new drugs. "There have been no significant advances or research into this disease area in decades," the company said in a statement. "For toxoplasmosis and other critical, under-treated diseases, the status quo is not an option. Turing hopes to change that by targeting investments that both improve on the current formulation and seek to develop new therapeutics with better clinical profiles that we hope will help eradicate the disease."
![]()
Company Will Lower Drug Price After Critics Called 4,000% Hike 'Unjustifiable'
The company also said that it would work with hospitals or patients on a case-by-case basis so that everyone can afford the medication. For privately insured patients, it said it would create a co-pay assistance program.In an interview with ABC News today Shkreli defended his company’s actions. “I think they have a fundamental misunderstanding of the way pharmaceutical companies operate,” he told ABC News of critics. “At this price, Daraprim is not a substantially profitable drug.”
Prior to Shkreli’s announcement, medical groups wrote to the company expressing their worries with the current price. The Infectious Diseases Society of America and the HIV Medicine Association released a joint statement earlier this week calling the prices "unjustifiable.” "Pyrimethamine (Daraprim) is currently part of the recommended first line treatment regimen for toxoplasmosis inHIV-infected patients and is a critical component of most of the alternative regimens," the groups said in the statement. "This cost is unjustifiable for the medically vulnerable patient population in need of this medication and unsustainable for the health care system."
Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center, said the disease can be acquired from cats and most often leads to symptoms in immunocompromised patients or pregnant women. It's a relatively rare disease that can be hard to treat and can cause swelling in the brain, he explained. "It's different than average bacterial infection. It requires more prolonged therapy, in part because it's a parasite and they're harder to treat," Schaffner said. "Their bodies can't fight off this infection. We treat longer ... about 3 or 4 weeks." Before Shkeil announced the company would lower the price, Schaffner said he was concerned doctors would look to use other drugs for treatment before starting Daraprim.
Company Will Lower Drug Price After Critics Called 4,000% Hike 'Unjustifiable'
Every single person I've talked to about this has stated the same thing.Democratic presidential candidate Bernie Sanders is calling on a drug company to justify a dramatic spike in the price of a 62-year-old drug that was reported Sunday.
One day before rival Hillary Clinton is set to propose a plan to rein in high costs for specialty drugs, Sanders in a letter to Turing Pharmaceuticals demanded an explanation for why the price of a drug used to treat dangerous parasitical infections leapt from $13.50 per tablet to $750 after the company acquired the drug from a competitor.
The price hike followed the sale of the drug, Daraprim, to Turing in August for $55 million, the New York Times reported.
“The enormous, overnight price increase for Daraprim is just the latest in a long list of skyrocketing price increases for certain critical medications,” wrote Sanders and Rep. Elijah Cummings, who are investigating sudden jumps in the costs of older, generic medicines.
Read more: Bernie Sanders questions drug price spike
That is a heck of a jump.
Tell me again how illegal Mexican labor is good for America.....Delta is ready when you are, asshole.yea its bleed them till they die......nice..real nice...people should not have to choose between meds and food or rent....greatest country in the world my ass
wutTyranny, that's the answer!This is why unregulated capitalism is evil.
We should force these companies to NEVER make a profit!!
and when they go out of business, well the GOVERNMENT can take over!!
Nice meltdown. I'll put you in the running for meltdown of the week.
The pope is awesome isn't he?Tyranny, that's the answer!This is why unregulated capitalism is evil.
We should force these companies to NEVER make a profit!!
and when they go out of business, well the GOVERNMENT can take over!!
You should try listening to the Pope for a change. It's much better than always viewing every national position as the human secondary position of importance before profit.
wutTyranny, that's the answer!This is why unregulated capitalism is evil.
We should force these companies to NEVER make a profit!!
and when they go out of business, well the GOVERNMENT can take over!!
Nice meltdown. I'll put you in the running for meltdown of the week.
I agree with you and you mad bro?
I mean I was just being honest about what you wanted. Just b/c you're not man enough to call it tyranny doesn't mean it's not.
so you are saying you don't want vast government control of our society?wutTyranny, that's the answer!This is why unregulated capitalism is evil.
We should force these companies to NEVER make a profit!!
and when they go out of business, well the GOVERNMENT can take over!!
Nice meltdown. I'll put you in the running for meltdown of the week.
I agree with you and you mad bro?
I mean I was just being honest about what you wanted. Just b/c you're not man enough to call it tyranny doesn't mean it's not.
You lied about what I wanted in a classic strawman absurdity of a meltdown.
The owner makes a completely bogus point. The drug has already been developed for 62 years.Martin Shkreli: Entrepreneur defends decision to raise price of life-saving drug 50-foldDemocratic presidential candidate Bernie Sanders is calling on a drug company to justify a dramatic spike in the price of a 62-year-old drug that was reported Sunday.
One day before rival Hillary Clinton is set to propose a plan to rein in high costs for specialty drugs, Sanders in a letter to Turing Pharmaceuticals demanded an explanation for why the price of a drug used to treat dangerous parasitical infections leapt from $13.50 per tablet to $750 after the company acquired the drug from a competitor.
The price hike followed the sale of the drug, Daraprim, to Turing in August for $55 million, the New York Times reported.
“The enormous, overnight price increase for Daraprim is just the latest in a long list of skyrocketing price increases for certain critical medications,” wrote Sanders and Rep. Elijah Cummings, who are investigating sudden jumps in the costs of older, generic medicines.
Read more: Bernie Sanders questions drug price spike
That is a heck of a jump.
This is capitalism. The owner makes a good point: if he is to innovate improvements in this drug someone needs to pay for it. Nobody has to buy the drug (there are alternative treatments) and if he doesnt sell any he will have to lower the price.
In any case this is irrelevant. The price increase was cancelled.
TB drug price cut—but still twice original cost